Research Article
[Retracted] Identification of a Novel Risk Model: A Five-Gene Prognostic Signature for Pancreatic Cancer
Table 1
KEGG pathways (top 20) associated with the differentially expressed genes between TCGA-PAAD tumor tissues with high and low prognostic risk scores.
| Description | Set size | ES | NES | value |
| KEGG_PATHWAYS_IN_CANCER | 320 | −0.45 | −1.87 | 1.29E − 03 | KEGG_REGULATION_OF_ACTIN_CYTOSKELETON | 206 | −0.44 | −1.76 | 1.39E − 03 | KEGG_FOCAL_ADHESION | 199 | −0.48 | −1.90 | 1.40E − 03 | KEGG_AXON_GUIDANCE | 128 | −0.44 | −1.65 | 1.49E − 03 | KEGG_TIGHT_JUNCTION | 129 | −0.49 | −1.84 | 1.49E − 03 | KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS | 110 | −0.50 | −1.85 | 1.51E − 03 | KEGG_CELL_CYCLE | 124 | −0.55 | −2.02 | 1.53E − 03 | KEGG_PYRIMIDINE_METABOLISM | 95 | −0.42 | −1.50 | 1.54E − 03 | KEGG_SMALL_CELL_LUNG_CANCER | 84 | −0.55 | −1.95 | 1.59E − 03 | KEGG_ECM_RECEPTOR_INTERACTION | 82 | −0.61 | −2.13 | 1.59E − 03 | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 74 | −0.51 | −1.77 | 1.63E − 03 | KEGG_ADHERENS_JUNCTION | 73 | −0.56 | −1.94 | 1.64E − 03 | KEGG_PANCREATIC_CANCER | 70 | −0.53 | −1.81 | 1.64E − 03 | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 67 | −0.56 | −1.91 | 1.64E − 03 | KEGG_P53_SIGNALING_PATHWAY | 68 | −0.53 | −1.79 | 1.66E − 03 | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 54 | −0.59 | −1.93 | 1.68E − 03 | KEGG_GLYCOLYSIS_GLUCONEOGENESIS | 57 | −0.52 | −1.69 | 1.70E − 03 | KEGG_PROTEASOME | 43 | −0.71 | −2.17 | 1.73E − 03 | KEGG_O_GLYCAN_BIOSYNTHESIS | 29 | −0.60 | −1.71 | 1.75E − 03 | KEGG_BLADDER_CANCER | 42 | −0.62 | −1.89 | 1.76E − 03 |
|
|
NES, normalized enrichment score. ES, enrichment score. overlapping pathways between GSEA and clusterProfiler functional enrichment analysis. |